Taiwan Liposome Co., Ltd. engages in the authorized cooperative development of special medicine as well as new formulation and prescription drugs. The firm offers pain management, ophthalmology, and oncology related drugs based on lipid drug delivery system. It also provides royalties and biotechnology services. The company was founded by Chi Lung Hung on November 10, 1997 and is headquartered in Taipei, Taiwan.
Company profile
Website
CEO
Jilong Hong
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
15-12B
Securities registration termination
27 Jan 22
6-K
Current report (foreign)
8 Oct 21
25
Voluntary exchange delisting
20 Sep 21
F-X
Appointment of agent for service of process by issuers registering securities
15 Sep 21
6-K
TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares
8 Sep 21
6-K
2021 Annual General Meeting Minutes
26 Aug 21
6-K
TLC Reports Second Quarter 2021 Financial Results
12 Aug 21
F-X
Appointment of agent for service of process by issuers registering securities
5 Aug 21
6-K
Notice of the First Extraordinary General Meeting of 2021
4 Aug 21
6-K
Current report (foreign)
22 Jul 21
Latest ownership filings
SC 13D/A
Lin Chang-Hai
8 Mar 22
SC 13D/A
Lin Chang-Hai
18 Feb 22
SC 13D/A
Lin Chang-Hai
10 Jan 22
SC 13D/A
Lin Chang-Hai
12 Nov 21
SC 13D/A
Lin Chang-Hai
20 Oct 21
SC 13D/A
Lin Chang-Hai
20 Aug 21
SC 13D
Lin Chang-Hai
15 Jul 21
SC 13G
Karst Peak Capital Ltd
16 Feb 21
SC 13G/A
Lin Chang-Hai
12 Feb 21
SC 13D/A
BURRILL LIFE SCIENCES CAPITAL FUND III L P
19 Jun 20
Financial summary
Quarter (USD) | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Institutional ownership, Q4 2021
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 5.74 mm |
Total shares | 47.43 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lin Chang-Hai | 46.13 mm | $0.00 |
Karst Peak Capital | 1.30 mm | $5.74 mm |